EBF1 and acute lymphoblastic leukemia: In this study, we sought to test whether deletion of IKZF1, dysregulation of CRLF2, JAK2 mutations, or deletions in PAX5 or EBF1 are prognostic determinants in Japanese pediatric BCP-ALL patients.